ARCHIVES

Blood Donors With Undertrain HTLV-3 Should Be Notified, Consensus Panel Says

This article is from The Cancer Letter archive.

Vol. 12 No. 29 | July 18, 1986

Download PDF Visit The Full Archive

Related Articles

In Brief: Abeloff, Fisher Lead ASCO; Henney Replaces Antman On Govt. Relations; Ultmann Retires

May 31, 1991

Cancer Policy: Board Plans Paper On Tobacco Control

June 13, 1997

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

February 17, 2006

Three researchers share Paul Marks Prize.

November 11, 2005

NCI Study Says 2 Million US Women Could Benefit from Tamoxifen

April 11, 2003

BMS Settles Charges Of Obstructing Generics

March 14, 2003